R&D Novel study designs for rare diseases Developing treatments for rare diseases poses many unique challenges that cannot be addressed by traditional study designs.
R&D Tech & Trials: Recruiting is hard, AI can make it easier Recruiting for clinical trials is hard… and expensive.
Patients 5 patient travel strategies to impact enrolment diversity in... According to the latest CISCRP report, “having to travel to the study clinic” is patients’ top-cited participation burden
R&D Clinical research is about trial and error Companies have been trying to expedite and optimise drug trials for ages.
News Phesi finds fifth of cancer trial sites recruit one patient Phesi, a global provider of patient-centric data analytics, has uncovered the urgent need for the clinical trials industry to address the issue of single-patient enrolment
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
